Depression
Conditions
Interventions
Experimental group: 240 dyads ( caregiver and children - Children under 12 years old) showing symptoms of depression, will be randomized to receive treatment through the TIP ( interpersonal therapy )
Other
Sponsors
Universidade Federal de São Paulo
Columbia Univertisy
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Depressive episode due to the presence of TDM according to the criteria of the DSMIVR received after administration of KSADS; score lower than 20 on the HDRS; both sex; be under 12 years old; parents must consent to participation by signing the informed consent form previously approved by the Ethics Committee of UNIFESP; preferably one caregiver to the child's mother with depressive episode due to TDM according to the DSMIVR criteria received after the SCIDI administration consent to the participation in the clinical trial.
Exclusion criteria
Exclusion criteria: Caregiver who receive treatment are using antidepressant medications or psychotherapy is in process; have a risk of suicide assessed by an item of PHQ9 scale, or have a score lower than 3 on the HAMD3, or through the clinical judgment of the SCID applicator; presents diagnostic criteria after administration of the SCIDI for psychoactive substances in the past 6 months; presents diagnostic criteria for bipolar disorder, schizophrenia or related disorders by administering the SCIDI; assumes that do not have the opportunity to follow the TIP sessions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction or remission of depression symptoms from the entry, seen through the result of depression assessment tool in caregivers (Hamilton Rating Scale for Depression - HDRS) from the observation of the variation of at least 50% in depression scores pre and post intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Decrease of psychiatric and behavioral symptoms in children , assessed by CBCL (Check -list for behavioral and emotional problems ) from the observation on ths scores changes, from clinic range (>61)at pre-intervention to normal range (<60)at post-intervention. | — |
Countries
Brazil
Contacts
Public ContactMarcelo de Mello
Universidade Federal de São Paulo
Outcome results
None listed